CareDx Q1 Revenues Grow 22 Percent

May 12, 2015

|

NEW YORK (GenomeWeb) – CareDx said after the close of the market on Tuesday that its first quarter revenues grew 22 percent year over year.

For the three months ended March 31, the Brisbane, California-based molecular diagnostics firm posted $7.2 million in revenues, up from $5.9 million in Q1 2014, and beating the consensus Wall Street estimate of $6.8 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Ah, Feel Full Now

People reports that researchers have uncovered genetic variants that lead people to always feel full.

Bill to Ease Post-Conviction DNA Testing Access

The Oregon state Senate unanimously passed a bill that would make it easier for people convicted of crimes to initiate DNA testing of evidence, according to the Associated Press.

Life Insurers, Too, in Florida?

Florida state senators are to weigh a bill prohibiting life insurance companies from using genetic information in coverage decisions, according to Florida Politics.

This Week in Genome Research

In Genome Research this week: metagenomic sequencing assay that detects pathogens in cerebrospinal fluid, single-tube long fragment read approach, and more.

Menu